Literature DB >> 17913805

Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells.

Guy Mlechkovich1, Niza Frenkel.   

Abstract

E2F transcription factors play pivotal roles in controlling the expression of genes involved in cell viability as well as genes involved in cell death. E2F1 is an important constituent of this protein family, which thus far contains eight members. The interaction of E2F1 with its major regulator, retinoblastoma protein (Rb), has been studied extensively in the past two decades, concentrating on the role of E2F1 in transcriptional regulation and the role of Rb in cell replication and cancer formation. Additionally, the effect of viral infections on E2F1/Rb interactions has been analyzed for different viruses, concentrating on cell division, which is essential for viral replication. In the present study, we monitored E2F1-Rb interactions during human herpesvirus 6A (HHV-6A) and HHV-6B infections of SupT1 T cells. The results have shown the following dramatic alterations in E2F1-Rb pathways compared to the pathways of parallel mock-infected control cultures. (i) The E2F1 levels were elevated during viral infections. (ii) The cellular localization of E2F1 was dramatically altered, and it was found to accumulate both in the cytoplasmic and nuclear fractions, as opposed to the strict nuclear localization seen in the mock-infected cells. (iii) Although E2F1 expression was elevated, two exemplary target genes, cyclin E and MCM5, were not upregulated. (iv) The Rb protein was dephosphorylated early postinfection, a trait that also occurred with UV-inactivated virus. (v) Infection was associated with significant reduction of E2F1/Rb complexing. (vi) HHV-6 infections were accompanied by cell cycle arrest. The altered E2F1-Rb interactions and functions might contribute to the observed cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913805      PMCID: PMC2168879          DOI: 10.1128/JVI.01496-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  84 in total

Review 1.  HHV-6 and seizures.

Authors:  Nobuko Yamashita; Tsuneo Morishima
Journal:  Herpes       Date:  2005-10

Review 2.  Emerging viral infections after hematopoietic cell transplantation.

Authors:  Michael Boeckh; Veronique Erard; Danielle Zerr; Janet Englund
Journal:  Pediatr Transplant       Date:  2005-12

3.  Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion.

Authors:  Masaya Takemoto; Masato Koike; Yasuko Mori; Sayoko Yonemoto; Yumi Sasamoto; Kazuhiro Kondo; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Estimating immunoregulatory gene networks in human herpesvirus type 6-infected T cells.

Authors:  Tomoiku Takaku; Junko H Ohyashiki; Yu Zhang; Kazuma Ohyashiki
Journal:  Biochem Biophys Res Commun       Date:  2005-10-21       Impact factor: 3.575

5.  Induction by herpes simplex virus of free and heteromeric forms of E2F transcription factor.

Authors:  M J Hilton; D Mounghane; T McLean; N V Contractor; J O'Neil; K Carpenter; S L Bachenheimer
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

6.  The retinoblastoma protein binds to a family of E2F transcription factors.

Authors:  J A Lees; M Saito; M Vidal; M Valentine; T Look; E Harlow; N Dyson; K Helin
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  Regulation of the cyclin E gene by transcription factor E2F1.

Authors:  K Ohtani; J DeGregori; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

8.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.

Authors:  K Helin; C L Wu; A R Fattaey; J A Lees; B D Dynlacht; C Ngwu; E Harlow
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

10.  Bone marrow transplant recipients harbor the B variant of human herpesvirus 6.

Authors:  N Frenkel; G C Katsafanas; L S Wyatt; T Yoshikawa; Y Asano
Journal:  Bone Marrow Transplant       Date:  1994-11       Impact factor: 5.483

View more
  11 in total

1.  Cloning human herpes virus 6A genome into bacterial artificial chromosomes and study of DNA replication intermediates.

Authors:  Ronen Borenstein; Niza Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

2.  Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes.

Authors:  Eyal Sharon; Ludmila Volchek; Niza Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-12       Impact factor: 11.205

Review 3.  Microscale electroporation: challenges and perspectives for clinical applications.

Authors:  Won Gu Lee; Utkan Demirci; Ali Khademhosseini
Journal:  Integr Biol (Camb)       Date:  2009-01-29       Impact factor: 2.192

4.  Virus reactivation: a panoramic view in human infections.

Authors:  Christopher M Traylen; Hersh R Patel; Wylder Fondaw; Sheran Mahatme; John F Williams; Lia R Walker; Ossie F Dyson; Sergio Arce; Shaw M Akula
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

5.  Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase.

Authors:  Lingyun Li; Bin Gu; Feng Zhou; Jing Chi; Fang Wang; Guangyong Peng; Fangyi Xie; Jian Qing; Dongju Feng; Shiqiang Lu; Kun Yao
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

6.  The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines.

Authors:  Ronen Borenstein; Haim Zeigerman; Niza Frenkel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

7.  The seroprevalence of Kaposi's sarcoma associated herpes virus and human herpes virus-6 in pediatric patients with cancer and healthy children in a Turkish pediatric oncology center.

Authors:  Nurdan Tacyildiz; Handan Ugur Dincaslan; Halil Ozdemir; Gulsan Yavuz; Emel Unal; Aydan Ikinciogullari; Figen Dogu; Deniz Guloglu; Emine Suskan; Kenan Kose
Journal:  Indian J Med Paediatr Oncol       Date:  2014-07

Review 8.  Breaking Bad: How Viruses Subvert the Cell Cycle.

Authors:  Ying Fan; Sumana Sanyal; Roberto Bruzzone
Journal:  Front Cell Infect Microbiol       Date:  2018-11-19       Impact factor: 5.293

9.  Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD.

Authors:  Junko Mori; Akiko Kawabata; Huamin Tang; Kenjiro Tadagaki; Hiroyuki Mizuguchi; Kazumichi Kuroda; Yasuko Mori
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

10.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome as a Hyper-Regulated Immune System Driven by an Interplay Between Regulatory T Cells and Chronic Human Herpesvirus Infections.

Authors:  Nuno Sepúlveda; Jorge Carneiro; Eliana Lacerda; Luis Nacul
Journal:  Front Immunol       Date:  2019-11-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.